Home » Saudi Investors »


|| Saudi investment firm Hevolution invested $20 million in US firm

Hevolution Foundation, a Saudi investment firm focused on aging science, has invested $20 million in Aeovian, a San Francisco based biopharmaceutical company.

Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted small molecules to restore cellular metabolic quality control. Hevolution has also invested in Rubedo Life Sciences $40 million Series A round. (Hevolution is a Saudi investment firm focused on aging science with an annual budget of up to $1 billion. They also invest in platforms and technologies that aim to compress drug development timelines or increase accessibility to therapeutics.)

Hevolution is listed in the Middle East Investors Directory with the code AJ49.


May 6, 2024 |  Filed under Saudi Investors

Previous Post: Saudi family offices of Watar Partners co-invested $700 million in New York food business
Next Post:

More from Saudi Investors ...


  Saudi investment firm Hevolution invested $20 million in US firm

  Saudi Investors of Riyad Valley acquired stake in California firm Solexel for $70 million

  Saudi and Bahrain investors acquired Byrne for $160 million

  Saudi investors of Alkhabeer acquired stake in Express Group

  Saudi investors of Alkhabeer acquired real estate in Houston

  Saudi family office acquired Four Seasons Toronto for $200 million

  Saudi private equity firm invested $45 million in 10 global companies

  Alkhabeer Capital to launch a $400 million fund

  Saudi Aramco to invest up to $120 million in Europe

  Saudi investors Al-Tuwairqi rescued UK steel firm out of administration





|| About Us

Established in 2007, DubaiBeat.com provides insight, analysis and research on Middle East investors.

We cover different asset class investors like private equity, venture capital, hedge funds and real estate investors from the Middle East and broader MENA region.










Copyright 2007-2024 DubaiBeat.com    Sitemap  |  Terms  |  Privacy Policy

Follow us: RSS Feed   LinkedIn    Twitter

Powered by Insightice